Pt Bundamedik Tbk · IDX:BMHS
Pt Bundamedik Tbk — FY2023 Earnings Presentation
23 slides from Pt Bundamedik Tbk's earnings presentation, April 2024
Slide 1: PT Bundamedik Tbk Analyst Meeting – 2023 Results
PT Bundamedik Tbk Analyst Meeting – 2023 Results April 2024 Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the contra
Slide 2: Leading Provider in Specialized Healthcare Services since 1973
Leading Provider in Specialized Healthcare Services since 1973
Slide 3: Bundamedik Tbk (BMHS) Ecosystem
Bundamedik Tbk (BMHS) Ecosystem Expanding Presence RSIA Az Zahra 10 HOSPITALS + 2 CLINICS Women & Children Hospitals 11 IVF CLINICS PADANG PONTIANAK BATAM 27 LABORATORIES Bunda Hospitals PALEMBANG MAKASSAR CLINICS NETWORK 1k++ (KLINIK PINTAR) YOGYAKARTA 126 FERTILITY CLINICS NETWORK (KFI) Jakarta De
Slide 4: 2023 Results
@punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA
Slide 5: 2023 Key Highlights
2023 Key Highlights 1 2 Core Hospital Revenue New Hospitals +15% +10% +109% Net Revenue YoY vs 3Q23 vs 2022 4Q23 Net revenue reached ATH +4% # of Outpatients +16% +9% +2% # of IP Days # of Lab Tests** -17% +159% +20pps -4% EBITDA Margin EBITDA improvement YoY improvement QoQ 3 Gross Profit Margin +2
Slide 6: Financial & Operational Performance
Financial & Operational Performance HIGHLIGHTS OF CONSOLIDATED RESULT Key Notes 3Q23 4Q23 QoQ (%) FY22 FY23 YoY (%) 1 OPERATIONALS 1 Core Business in FY23 • Hospitals metrics: mostly grew in #Outpatients, #IP Admission and #surgeries, # Outpatient 148,4 154,9 4% 485,7 565,6 16% however, #IP Days dec
Slide 7: Hospitals Volume
Hospitals Volume # OUTPATIENTS # IP ADMISSION +10% +18% +16% +15% +48% 148.4 154.9 +92% 11.4 11.3 133.9 128.3 9.8 10.0 565.6 42.5 485.7 34.4 383.1 359.6 390.5 22.1 21.3 21.3 2019 2020 2021 2022 2023 1Q23 2Q23 3Q23 4Q23 2019 2020 2021 2022 2023 1Q23 2Q23 3Q23 4Q23 # IP DAYS # SURGERIES +13% +20% +27%
Slide 8: Financial Performance
Financial Performance Consolidated NET REVENUE EBITDA Margin EBITDA Net Core Revenue (Rp B) Covid EBITDA (Rp B,% Margin) Net Covid Revenue Core EBITDA +4% +13% 30% 28% +62% 1.518 1.461 460 5% 23% 23% 1.288 25% 187 324 934 261 33 795 8% 215 39 17% 95% 185 100% 75% 92% 273 291 100% 221 215 185 2019 20
Slide 9: Balance Sheet
Balance Sheet Remains healthy CASH VS DEBT NET DEBT-TO-EBITDA (Rp B) (x) Net 418 -135 -216 225 405 Debt 2.2x 1.027 1.9x 830 855 0.7x 625 613 629 622 518 490 100 -0.6x -0.4x 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 AR Days WORKING CAPITAL DAYS Inventory Days 58 53 AP Days 46 43 40 29 29 30 2
Slide 10: IVF Cycles
IVF Cycles Initiatives in progress to increase cycle performance # OF IVF CYCLES (‘000) +4% 5.84 5.74 5.08 4.90 4.12 2019 2020 2021 2022 2023
Slide 11: Diagnos: Focusing on genomic testing
Diagnos Focusing on genomic testing Covid # OF TESTS (‘000) 265 Non Covid 888 35% 170 214 239 11% 172 163 175 176 766 23% 686 -4% 20% 32% 4% YoY Non Covid 8% 2% 1% 481 22% 5% Test Volume 89% 31% 99% 77% 96% 65% 80% 92% 95% 98% 68% 78% 69% 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 2020 2021 2022 2023 R
Slide 12: Strengthening Our Core
Strengthening Our Core @punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA
Slide 13: Strengthening Our COEs
Strengthening Our COEs GynROSE Clinic Robotic Surgery Bunda Neuro Center Eras NICU/PICU Laparoskopi Bunda Health Center RSM Oncology Bunda General Hospital Bunda Women & Children Hospital Jakarta Klinik Tumbuh Kembang Anak Bunda Endoscopy Center
Slide 14: Update Hospitals Result Initiatives
Update Hospitals Result Initiatives Revenue Per payor: 2022 2023 Hospitals improvement perspective: 2% • Increased +1pps in Corporate and Insurance 15% 20% payor align with our initiatives Kemenkes BPJS 41% 42% • Bunda well-known for OBGYN and Pediatric specialization, this year we grow other COEs O
Slide 15: Ensuring Standardised Quality Process
Ensuring Standardised Quality Process
Slide 16: 2023 Update & 2024 Initiatives
2023 Update & 2024 Initiatives
Slide 17: Our New Hospitals Performance
Our New Hospitals Performance 172 60++ 2 1 Beds Specialist Doctors W&C Hospitals General Hospital Core Net Revenue EBITDA Financial optimization • 4Q23 net revenue +85% QoQ record all- 80,424 6,223 time-high in 2023 and EBITDA +20% QoQ. • In line with our expectations, FY23 reached positive EBITDA +
Slide 18: Annualized Cost Efficiency
Annualized Cost Efficiency BPJS Update Identified potential improvement With intensive quality and cost control for BPJS services, update from two of our hospital result in before and after improvement in our Gross Margin Before After Improvement initiative initiative 4 Months Initiative BPJS GPM of
Slide 19: Annualized Cost Efficiency
Annualized Cost Efficiency Key value Identified potential improvement ✓ Equipment cost transformation saving 4 Months Initiative • 5-10% cost saving per specific specialization through purchase medical Rp 5.5 Bn Cost Efficiency equipment, negotiation, and formulary change ✓ Asset tracking and utiliz
Slide 20: 2024 Key Focus Area
2024 Key Focus Area Expansion of our Center of 1 2 Engage in more Corporate and Excellence and Product of Insurance partnerships Excellence Key Focus Area 2024 Improve core functions to 5 3 Ramp up the performance of achieve operational our newly acquired hospitals excellence 4 Focusing on the expan
Slide 21: Morula 2024 Initiatives
Morula 2024 Initiatives Action plan Increase New Female Patients ✓ Attract good quality New Female Patients Acquisition ✓ Patient Profiling and Segmentation ✓ Initiate Team Doctor Programs Improve Doctor Productivity ✓ Acquisition and Development of Top Doctors ✓ Seamless patient journey Improve Qua
Slide 22: OneBunda: ~59K Transaction
189.067 (Existing Non-BPJS Patients) As of 31 December 2023, 40% Of existing Bunda's patients (non BPJS) have registered and used OneBunda Most Frequently Used Features is Janji Temu that generate ~59K Transaction 75.315 OneBunda’s Unique Users
Slide 23: Thank You
THANK YOU Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the contrary. Specific data in this presentation was obtaine